tiprankstipranks
Trending News
More News >
Beyondspring Inc (BYSI)
NASDAQ:BYSI
US Market
Advertisement

Beyondspring (BYSI) Price & Analysis

Compare
324 Followers

BYSI Stock Chart & Stats


Financials

Options Prices

Currently, No data available
---

Ownership Overview

12.30%0.07%12.27%73.97%
12.30%
Insiders
12.27% Other Institutional Investors
73.97% Public Companies and
Individual Investors

BYSI FAQ

What was Beyondspring Inc’s price range in the past 12 months?
Beyondspring Inc lowest stock price was $0.98 and its highest was $3.44 in the past 12 months.
    What is Beyondspring Inc’s market cap?
    Beyondspring Inc’s market cap is $75.39M.
      When is Beyondspring Inc’s upcoming earnings report date?
      Beyondspring Inc’s upcoming earnings report date is Sep 05, 2025 which is in 41 days.
        How were Beyondspring Inc’s earnings last quarter?
        Beyondspring Inc released its earnings results on May 12, 2025. The company reported $0.11 earnings per share for the quarter, beating the consensus estimate of N/A by $0.11.
          Is Beyondspring Inc overvalued?
          According to Wall Street analysts Beyondspring Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Beyondspring Inc pay dividends?
            Beyondspring Inc does not currently pay dividends.
            What is Beyondspring Inc’s EPS estimate?
            Beyondspring Inc’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Beyondspring Inc have?
            Beyondspring Inc has 40,316,320 shares outstanding.
              What happened to Beyondspring Inc’s price movement after its last earnings report?
              Beyondspring Inc reported an EPS of $0.11 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 4.242%.
                Which hedge fund is a major shareholder of Beyondspring Inc?
                Currently, no hedge funds are holding shares in BYSI

                Beyondspring Stock Smart Score

                4
                Neutral
                1
                2
                3
                4
                5
                6
                7
                8
                9
                10

                Technicals

                SMA
                Positive
                20 days / 200 days
                Momentum
                -11.79%
                12-Months-Change

                Fundamentals

                Return on Equity
                78.44%
                Trailing 12-Months
                Asset Growth
                -36.44%
                Trailing 12-Months

                Company Description

                Beyondspring Inc

                BeyondSpring Inc. (NASDAQ: BYSI) is a global biopharmaceutical company focused on the development and commercialization of innovative cancer therapies. Headquartered in New York City, the company is dedicated to improving clinical outcomes for patients with high unmet medical needs. BeyondSpring's lead asset, Plinabulin, is a first-in-class immune-oncology agent that is being developed as a potential treatment for chemotherapy-induced neutropenia and non-small cell lung cancer. The company's pipeline includes additional oncology assets in various stages of development.
                Similar Stocks
                Company
                Price & Change
                Follow
                Adicet Bio
                Precision BioSciences
                Ikena Oncology
                MAIA Biotechnology, Inc.
                Acrivon Therapeutics, Inc.
                Popular Stocks
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis